Latest chemoprevention Stories
Orange juice contains vitamin C and several other key nutrients, and has also been linked to a reduced risk of obesity in adults, but recently-published research suggests that it could also help prevent cancer.
Giving young children medicine once a month during the rainy season to protect them against malaria could prevent tens of thousands of deaths each year in some areas of Africa.
Scientists have identified a biomarker for measuring the success of lung cancer chemoprevention, an emerging frontier in the fight against this disease that has long been stymied by a lack of measureable outcomes.
The popular drug dutasteride may not be a cost-effective way to prevent prostate cancer in men who are at elevated risk of developing the disease.
Researchers at Duke University Medical Center have identified a possible biomarker for measuring progress in breast cancer chemoprevention trials.
Since the isolation and culture of Helicobacter pylori (H. pylori) in 1983, this bacterium has become accepted as an important human pathogen for the development of gastritis, peptic ulcer, and gastric cancer. Cyclooxgenase-2 (COX-2) is a prostaglandin-synthesizing enzyme.
The compound, Î±-difluoromethylornithine or DFMO, targets the activity of a specific enzyme and, even in very limited doses, is effective in protecting against the malignancy in animal models.
New research strongly suggests that a mix of preventative agents, such as those found in concentrated black raspberries, may more effectively inhibit cancer development than single agents aimed at shutting down a particular gene.
U.S. cancer researchers say they have developed a chemoprevention gene therapy that successfully kills pancreatic cancer cells.
By Xu, Cheng-Xiong Jere, Dhananjay; Jin, Hua; Chang, Seung-Hee; Chung, Youn-Sun; Shin, Ji-Young; Kim, Ji-Eun; Park, Sung-Jin; Lee, Yong- Hoon; Chae, Chan-Hee; Lee, Kee Ho; Beck, George R Jr; Cho, Chong- Su; Cho, Myung-Haing Rationale: The low efficiency of conventional therapies in achieving long-term survival of patients with lung cancer calls for the development of novel therapeutic options.